Serum Levels of Plexin B2 in Psoriasis: A case-control study | ||||
| SVU-International Journal of Medical Sciences | ||||
| Article 102, Volume 8, Issue 1, January 2025, Page 1164-1171 PDF (336.09 K) | ||||
| Document Type: Original research articles | ||||
| DOI: 10.21608/svuijm.2023.238786.1708 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Eisa M. Hegazy1; Moustafa A El- Taieb2; Mohammed Hassan 3; Ebtehal A El-Din  1; Hassan M. Ibrahim1
| ||||
| 1Dermatology, Venereology &Andrology Department , Faculty of Medicine, South Valley University, Qena, Egypt. | ||||
| 2Dermatology ,Venereology& Andrology Department ,Faculty of Medicine, Aswan University , Aswan, Egypt. | ||||
| 3Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena, Egypt | ||||
| Abstract | ||||
| Background: Psoriasis is a severe, long-lasting, immune-mediated, hyperproliferative, and inflammatory skin condition that can cause painful or itchy lesions and have a significant impact on quality of life. Psoriasis' complex and poorly understood etiopathogenesis.PlxinB2 has an impact on T-cell morphology that is mediated via CD100. Consequently, they play a function throughout an immune response. Objectives: Asses serum level of plexin B2 in psoriatic patients& find any possible correlation between serum level of plexin B2 and Psoriasis Area and Severity Index (PASI) score. Patients and methods: Cross sectional-case control study was carried on psoriatic patients who came to the Dermatology Outpatient Clinic of South Valley University Hospitals. The study started with 50 psoriatic patients& 50 controls healthy individuals unrelated, age, sex, BMI matched with volunteers. The Psoriasis Area and Severity Index score ( PASI ) used for evaluation of psoriasis vulgaris severity, then serum plexin-b2 level was measured using commercial available ELISA Assay kit . Results: Regarding patient’s age, the 2 groups were matched for age (p=0.064). Likewise, the mean BMI (p = 0.614) sex distribution was comparable in all groups with (p =1.000), there was significantly higher mean of serum Plexin-B2 in cases (10.3 ± 2.3 pg/ml) compared to control (4.3 ± 0.3, p<0.001 pg/ml) (p=0.011), there was significant (<0.001) positive high correlation between s. plexin-b2 and disease severity (r=0.703), Conclusion: The current work confirming high serum plexin-b2 in psoriasis vulgaris in a high significant manner with the disease severity so, plexin-b2 may have role in psoriasis vulgaris pathogenesis. | ||||
| Keywords | ||||
| Psoriasis vulgaris; Plexin-b2; PASI | ||||
|
Statistics Article View: 80 PDF Download: 65 |
||||
